ProfileGDS4132 / 233313_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 29% 36% 29% 26% 31% 35% 33% 32% 30% 27% 33% 31% 31% 40% 24% 25% 31% 31% 33% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10172.052429
GSM201543Muscle PCOS pioglitazone 12184.052236
GSM201544Muscle PCOS pioglitazone 16173.437729
GSM201545Muscle PCOS pioglitazone 20170.015226
GSM201829Muscle PCOS pioglitazone 23181.966931
GSM201830Muscle PCOS pioglitazon 25192.575535
GSM201831Muscle PCOS pioglitazone 27181.108533
GSM201832Muscle PCOS pioglitazone 3181.179532
GSM201833Muscle PCOS pioglitazone 4170.504630
GSM201834Muscle PCOS pioglitazone 8162.744427
GSM201835Muscle PCOS after pioglitazone 10269.830133
GSM201836Muscle PCOS after pioglitazone 12265.146431
GSM201837Muscle PCOS after pioglitazone 16264.332631
GSM201838Muscle PCOS after pioglitazone 20294.379540
GSM201839Muscle PCOS after pioglitazone 23251.405124
GSM201840Muscle PCOS after pioglitazone 25257.445725
GSM201841Muscle PCOS after pioglitazone 27261.718931
GSM201842Muscle PCOS after pioglitazone 3260.078131
GSM201843Muscle PCOS after pioglitazone 4279.480833
GSM201844Muscle PCOS after pioglitazone 8271.117331